Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, Follow-up Study to Assess the Long-term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in Patients With an Implantable Cardioverter Defibrillator

NCT00751738 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00751738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00751738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, Follow-up Study to Assess the Long-term Safety of 125 mg Per Day of Oral Azimilide Dihydrochloride in Patients With an Implantable Cardioverter Defibrillator
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
October 31, 2005
Enrollment
330 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias